
The Telangana Drugs Control Administration (DCA) has issued show-cause notices to 43 medical shops after a statewide enforcement drive on August 14 detected violations in the sale of weight loss drugs such as Mounjaro, Ozempic, Wegovy and Rybelsus. The DCA said inspections focused on drugs containing Tirzepatide and Semaglutide, including generic equivalents, with special attention to spurious or counterfeit batches. Officials found non-compliance including sale without a prescription, failure to issue bills, and dispensing medicines without a registered pharmacist. Further action under the Drugs and Cosmetics Act, 1940 is pending.


The DCA drive rightly targets an unregulated trade in injectable weight-loss drugs that should require specialist oversight, not a pharmacy counter. But headlines about 43 shops raided risk amplifying fear over what were mostly administrative slip-ups like missing registers and absent pharmacists. The real test will be how many of those notices lead to actual prosecutions for selling dangerous counterfeits, not just bill-book fines under a 1940 Act. How many confirmed spurious vials has the DCA actually seized? That number will tell us if this was a meaningful crackdown or a paperwork raid.
Sources (2): siasat.com, thehindu.com
This story was synthesised by AI from the 2 sources linked above. Methodology and corrections.
Updated: this story now draws on 2 sources.